A detailed genomic and epidemiological investigation of the 2025 Ebola disease outbreak in Bulape Health Zone, located in the Kasaï Province of the Democratic Republic of the Congo, has revealed that the causative Orthoebolavirus zairense strains formed a well-supported phylogenetic cluster with the ancestral 1976 Yambuku-Mayinga lineage. The outbreak, officially declared by the Ministry of Public Health, Hygiene and Social Welfare on 4 September 2025 and concluded on 1 December 2025, marked the nation’s sixteenth documented confrontation with the deadly filovirus. By generating full-length viral genomes from initial diagnostic specimens collected during the early phase of the epidemic, researchers established that the episode was not a re-emergence of strains from past regional outbreaks in neighboring Luebo or Mweka, but rather the result of a probable novel zoonotic spillover originating from an unidentified natural animal reservoir.
The setting of the outbreak in Bulape presents substantial operational and logistical complexities, situated across an expansive rural zone spanning approximately 6533 square kilometers with an estimated population of 350,300 inhabitants. Healthcare facilities in this remote sector operate with constrained infrastructure, diagnostic resources, and clinical protective capacity. Although the epicenter was located merely 40 kilometers from the historical sites of the 2007 and 2008 Ebola virus disease outbreaks in Luebo and Mweka, phylogenetic separation firmly demonstrated that dormant viral chains or reactivation among local survivors from those historical events were not responsible. Instead, the emergence of a genomic profile showing intimate evolutionary ties to the very first recognized Ebola lineage discovered five decades earlier presents compelling questions regarding how filoviruses persist and evolve across ecological niches in Central Africa.
Clinical reconstruction carried out through interviews with frontline medical staff and systematic examination of patient records at the General Referral Hospital of Bulape identified the probable index patient as a young pregnant woman between 20 and 29 years of age. Residing in the Bulape Health Zone and carrying a pregnancy estimated between 32 and 36 weeks of gestation, she reported consuming wild rodent game shortly prior to experiencing the onset of non-specific systemic symptoms, including persistent fever, intense headache, and abdominal pain. After symptomatic progression spanning approximately one week, she was initially admitted in mid-August 2025 to the Bulape Health Center Poste III exhibiting vaginal hemorrhage alongside febrile illness. She was subsequently transferred to the referral hospital under a provisional diagnosis of malaria, receiving intravenous quinine, ceftriaxone, metronidazole, and tocolytic therapies.
The clinical course of the index patient deteriorated rapidly within the hospital setting, culminating in the stillbirth of a 1.700-kilogram infant on the day following admission. Two days post-admission, the patient manifested acute hemorrhagic signs, including hematemesis and bloody diarrhea accompanied by severe anemia that necessitated emergency blood transfusions, before ultimately succumbing on her fourth hospital day. She was subsequently buried within the community without the protection of safe and dignified burial protocols, and no diagnostic specimens could be collected prior to interment. In the days following her demise, secondary transmission propagated aggressively within the maternity ward and household contacts, establishing a transmission chain that directly infected visiting relatives, bedside co-patients, and essential clinical staff who had performed blood collection and direct patient management.
The early transmission cluster evaluated during the investigative period comprised eleven clinical cases, categorized into six probable cases and five laboratory-confirmed infections. Among healthcare workers at the Bulape hospital, exposure during venipuncture and routine caretaking proved particularly hazardous; a laboratory technician and a trainee technician contracted the infection following blood collection, while two attending midwives were similarly infected, one of whom sustained an accidental needle-stick injury. Secondary amplification within the healthcare infrastructure was further observed when the infected trainee technician subsequently drew diagnostic blood samples from two pediatric patients hospitalized within the pediatric ward. Household transmission simultaneously touched the index patient’s young child, aged two to five years, alongside an aunt who had assisted in caretaking duties.
Formal diagnostic verification commenced when six initial clinical specimens, comprising one post-mortem oral swab from a deceased midwife and five plasma samples from exposed hospital personnel and pediatric patients, arrived at the Institut National de Recherche Biomédicale reference laboratory in Kinshasa on 3 September 2025. Laboratory teams subjected these specimens to molecular evaluation using point-of-care GeneXpert Ebola assays on the swab matrix, automated BioFire FilmArray Global Fever Panels capable of detecting 19 pathogens, and real-time reverse transcription polymerase chain reaction via the Altona RealStar Filovirus Screen RT-PCR kit. Five of the six specimens yielded positive results for Orthoebolavirus zairense, with concordant amplification observed across platforms for four samples, while a single convalescent plasma specimen exhibited discordant positivity on BioFire alone, attributable to very low circulating viral load.
To reconstruct the genomic identity of the circulating pathogen, researchers performed targeted multiplex PCR tiling using primer pools optimized for the 2018–2020 eastern Democratic Republic of the Congo outbreaks, sequencing cDNA libraries on Oxford Nanopore GridION hardware with R10.4.1 flowcells. Four complete viral genomes achieving greater than 98 percent horizontal coverage were assembled using the amplicon-nf pipeline with Dorado basecalling. To confirm the validity of base calls derived from amplicon approaches and rule out amplification artifacts, the team performed orthogonal probe-based capture sequencing on an index specimen utilizing the Twist Comprehensive Viral Research panel. The probe-derived consensus sequence demonstrated 100 percent nucleotide identity with the amplicon-based assembly, providing independent verification of the shared mutational profile.
Phylogenetic trees reconstructed under maximum likelihood frameworks using IQ-TREE and general time-reversible nucleotide substitution models placed the Bulape genomes into an evolutionary branch rooted directly alongside the 1976 Yambuku-Mayinga prototype sequence. Intriguingly, the total evolutionary branch length separating the 2025 lineage from the 1976 ancestor was remarkably shorter than expected under standard molecular clock assumptions for filoviruses, which typically accumulate approximately 1.9 × 10⁻³ substitutions per site each year, or roughly one substitution every ten days during active human epidemics. This observed divergence deficit suggests either prolonged periods of reduced replication within natural sylvatic reservoirs, specialized viral latency within an undocumented past human survivor, or evolutionary dynamics in unknown ecological hosts that diverge from typical epidemic evolutionary tempos.
Within the sequenced outbreak genomes, fine-scale genomic analysis uncovered evidence of host-mediated viral editing. Specifically, the genome isolated from a pediatric patient, designated 25FHV168, exhibited six distinct thymine-to-cytosine transitions clustered entirely within a 101-nucleotide span beginning at nucleotide position 2812. This localized hypermutation pattern matches the enzymatic signature characteristic of host Adenosine Deaminase Acting on RNA editing enzymes. After analytically masking these six hypermutations to prevent statistical distortion of phylogenetic signals, sixteen informative substitutions remained across the 2025 outbreak alignment. Two of these substitutions exhibited phylogenetic incompatibility, representing either reverse mutations, homoplasic evolutionary events, or technical sequencing variations across low-frequency amplicons.
By the time the outbreak was formally declared terminated on 1 December 2025, public health authorities had documented a cumulative total of 64 cases, encompassing 53 laboratory-confirmed and 11 probable cases, alongside 45 cumulative fatalities, reflecting a case-fatality rate of 64 percent among confirmed individuals. The rapid generation of high-confidence genomic data early in the outbreak provided decisive biological evidence confirming the antigenic suitability of the rVSV-ZEBOV vesicular stomatitis virus-vectored vaccine. Deployment of ring vaccination strategies across Bulape Health Zone facilitated the immunization of more than 30,000 at-risk individuals and contacts, successfully arresting transmission chains despite severe infrastructure hurdles and illustrating the pivotal role of mobile real-time genomic surveillance in contemporary containment responses.
Subject of Research: Genomic and epidemiological investigation of the 2025 Ebola disease outbreak in the Democratic Republic of the Congo
Article Title: Phylogenetic analysis of the 2025 Ebola outbreak in the Democratic Republic of the Congo
Article References: Amuri-Aziza, A., Luakanda-Ndelemo, G., Makangara-Cigolo, J.-C., Kinganda-Lusamaki, E., Ngandu, C., Bula-Loso, S., Mossoko, M., Tshulo, L., Akil-Bandali, P., Kitenge-Omasumbu, R., Jansen, D., Brosius, I., Lokilo-Lofiko, E., Kimbonza, S., Paku-Tshambu, P., Ngonda-Tshibinda, A., Kuispond-Swar, N.-R., Ayouba, A., Nsio, J., … Mbala-Kingebeni, P. (2026). Phylogenetic analysis of the 2025 Ebola outbreak in the Democratic Republic of the Congo. Nature Communications, 17(1), Article 10521. https://doi.org/10.1038/s41467-026-77542-9
Image Credits: AI Generated
DOI: 10.1038/s41467-026-77542-9
Keywords: Ebola virus disease, Orthoebolavirus zairense, Democratic Republic of the Congo, Bulape Health Zone, phylogenetic analysis, whole-genome sequencing, zoonotic spillover, outbreak investigation, molecular diagnostics, GeneXpert Ebola assay, BioFire FilmArray, nanopore sequencing, ADAR-mediated editing, transmission chain, nosocomial infection, rVSV-ZEBOV vaccine, epidemiology
Tags: ADAR-mediated editingBioFire FilmArrayBulape Health ZoneDemocratic Republic of the CongoEbola virus diseaseEpidemiologyGeneXpert Ebola assayMolecular diagnosticsNanopore Sequencingnosocomial infectionOrthoebolavirus zairenseoutbreak investigationPhylogenetic analysisrVSV-ZEBOV vaccinetransmission chainwhole-genome sequencingzoonotic spillover




